Is Chemours Stock a Good Investment?

Chemours Investment Advice

To provide specific investment advice or recommendations on Chemours Co stock, we recommend investors consider the following general factors when evaluating Chemours Co. This will help you to make an informed decision on whether to include Chemours in one of your diversified portfolios:

Examine Chemours' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Chemours' leadership team and their track record. Good management can help Chemours navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Diversified Chemicals space and any emerging trends that could impact Chemours' business and its evolving consumer preferences.
Compare Chemours' performance and market position to its competitors. Analyze how Chemours is positioned in terms of product offerings, innovation, and market share.
Check if Chemours pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Chemours' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Chemours Co stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Chemours Co is a good investment.

Sell

Buy

Strong Buy

Our trade advice tool can cross-verify current analyst consensus on Chemours and to analyze the company potential to grow in the current economic cycle. To make sure Chemours is not overpriced, please confirm all Chemours fundamentals, including its shares owned by institutions, price to sales, and the relationship between the shares outstanding and price to earning . Given that Chemours has a price to earning of 25.49 X, we suggest you to validate Chemours Co market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Market Performance	Very Weak	Details
Volatility	Not too volatile	Details
Hype Condition	Over hyped	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Low	Details
Economic Sensitivity	Responds to the market	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Buy	Details
Financial Strenth (F Score)	Healthy	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Possible Manipulator	Details

Examine Chemours Stock

Researching Chemours' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 86.0% of the company shares are held by institutions such as insurance companies. The book value of Chemours was currently reported as 4.04. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Chemours last dividend was issued on the 28th of February 2025.

To determine if Chemours is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Chemours' research are outlined below:

	Chemours generated a negative expected return over the last 90 days
	Chemours Co reports about 1.1 B in cash with (633 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.73.
	Over 86.0% of the company shares are held by institutions such as insurance companies
	Latest headline from thefly.com: Chemours price target lowered by 4 at Barclays, heres why CC

Chemours Quarterly Liabilities And Stockholders Equity

7.51 Billion

Chemours uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Chemours Co. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Chemours' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	14th of February 2024 Upcoming Quarterly Report	View
	25th of April 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	14th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact Chemours' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Chemours' investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2016-05-02	2016-03-31	0.02	0.06	0.04	200
2025-02-26	2024-12-31	0.1559	0.11	-0.0459	29
2024-03-27	2023-12-31	0.25	0.31	0.06	24
2017-02-15	2016-12-31	0.29	0.35	0.06	20
2015-11-05	2015-09-30	0.26	0.19	-0.07	26
2021-05-03	2021-03-31	0.63	0.71	0.08	12
2020-07-30	2020-06-30	0.1	0.18	0.08	80
2016-02-23	2015-12-31	0.08	0.16	0.08	100

Chemours Target Price Consensus

Chemours target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Chemours' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.

Buy

Most Chemours analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Chemours stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Chemours, talking to its executives and customers, or listening to those companies' conference calls.

Macroaxis Advice Exposure Valuation

Chemours Target Price Projection

Chemours' current and average target prices are 15.80 and 24.22, respectively. The current price of Chemours is the price at which Chemours Co is currently trading. On the other hand, Chemours' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Chemours Market Quote on 25th of February 2025

Low Price	14.94	Odds
High Price	16.32	Odds

15.8 Target Price

Analyst Consensus On Chemours Target Price

Low Estimate	22.04	Odds
High Estimate	26.89	Odds

24.2222

Historical

Lowest Forecast 22.04

Target Price 24.22

Highest Forecast 26.89

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Chemours Co and the information provided on this page.

Chemours Analyst Ratings

Chemours' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Chemours stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Chemours' financials, market performance, and future outlook by experienced professionals. Chemours' historical ratings below, therefore, can serve as a valuable tool for investors.

Know Chemours' Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Chemours is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chemours Co backward and forwards among themselves. Chemours' institutional investor refers to the entity that pools money to purchase Chemours' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Ubs Group Ag	2024-12-31	2.1 M
Norges Bank	2024-12-31	1.8 M
Dimensional Fund Advisors, Inc.	2024-12-31	1.8 M
American Century Companies Inc	2024-12-31	1.6 M
Massachusetts Financial Services Company	2024-12-31	1.6 M
Morgan Stanley - Brokerage Accounts	2024-12-31	1.6 M
Vision One Management Partners Lp	2024-12-31	1.6 M
Scopia Management Inc	2024-12-31	1.4 M
Charles Schwab Investment Management Inc	2024-12-31	1.3 M
Blackrock Inc	2024-12-31	16.8 M
Vanguard Group Inc	2024-12-31	15.2 M

Note, although Chemours' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Chemours' market capitalization trends

The company currently falls under 'Mid-Cap' category with a market capitalization of 2.5 B.

Market Cap

4.81 Billion

Chemours' profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	0.01	0.01
Return On Capital Employed	0.08	0.13
Return On Assets	0.01	0.01
Return On Equity	0.14	0.18

The company has Net Profit Margin (PM) of 0.01 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.03 %, which signifies that for every $100 of sales, it has a net operating income of $0.03.

Determining Chemours' profitability involves analyzing its financial statements and using various financial metrics to determine if Chemours is a good buy. For example, gross profit margin measures Chemours' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Chemours' profitability and make more informed investment decisions.

Please note, the presentation of Chemours' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chemours' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chemours' management manipulating its earnings.

Evaluate Chemours' management efficiency

Chemours has Return on Asset (ROA) of 0.0349 % which means that for every $100 of assets, it generated a profit of $0.0349. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.128 %, which means that it produced $0.128 on every 100 dollars invested by current stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. At present, Chemours' Return On Equity is projected to slightly decrease based on the last few years of reporting. At present, Chemours' Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.62, whereas Non Current Assets Total are forecasted to decline to about 4.5 B.

	Last Reported	Projected for Next Year
Book Value Per Share	4.05	3.84
Tangible Book Value Per Share	3.72	7.43
Enterprise Value Over EBITDA	8.91	8.66
Price Book Value Ratio	4.18	8.14
Enterprise Value Multiple	8.91	8.66
Price Fair Value	4.18	8.14
Enterprise Value	6.2 B	5.3 B

Chemours showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.

Dividend Yield

0.0597

Forward Dividend Yield

0.0597

Forward Dividend Rate

Beta

1.804

Basic technical analysis of Chemours Stock

As of the 25th of February, Chemours shows the risk adjusted performance of (0.04), and Mean Deviation of 2.1. Chemours technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Chemours' insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chemours insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chemours' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chemours insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Kava Joseph Daniel over a month ago Insider Trading
		Kristine Wellman over two months ago Acquisition by Kristine Wellman of 20671 shares of Chemours at 27.5 subject to Rule 16b-3
		Picho Diane I. over three months ago Disposition of tradable shares by Picho Diane I. of Chemours at 19.04 subject to Rule 16b-3
		Alvenia Scarborough over three months ago Acquisition by Alvenia Scarborough of 7903 shares of Chemours at 27.5 subject to Rule 16b-3
		Shane Hostetter over six months ago Acquisition by Shane Hostetter of 26709 shares of Chemours subject to Rule 16b-3
		Hostetter Shane over six months ago Insider Trading
		Camela Wisel over a year ago Acquisition by Camela Wisel of 5425 shares of Chemours subject to Rule 16b-3

Chemours' Outstanding Corporate Bonds

Chemours issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chemours uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chemours bonds can be classified according to their maturity, which is the date when Chemours Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	US163851AH15 Corp Bond US163851AH15	View
	US163851AF58 Corp Bond US163851AF58	View
	Chemours 5375 percent Corp Bond US163851AE83	View

View All Chemours Corporate Bonds

Understand Chemours' technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Chemours' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	(0.04)
	Market Risk Adjusted Performance	(0.13)
	Mean Deviation	2.1
	Coefficient Of Variation	(1,517)
	Standard Deviation	2.95
	Variance	8.72
	Information Ratio	(0.07)
	Jensen Alpha	(0.20)
	Total Risk Alpha	(0.19)
	Treynor Ratio	(0.14)
	Maximum Drawdown	16.32
	Value At Risk	(4.67)
	Potential Upside	3.86
	Skewness	0.6857
	Kurtosis	3.02

	Risk Adjusted Performance	(0.04)
	Market Risk Adjusted Performance	(0.13)
	Mean Deviation	2.1
	Coefficient Of Variation	(1,517)
	Standard Deviation	2.95
	Variance	8.72
	Information Ratio	(0.07)
	Jensen Alpha	(0.20)
	Total Risk Alpha	(0.19)
	Treynor Ratio	(0.14)
	Maximum Drawdown	16.32
	Value At Risk	(4.67)
	Potential Upside	3.86
	Skewness	0.6857
	Kurtosis	3.02

Consider Chemours' intraday indicators

Chemours intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Chemours stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	305102.0
	Daily Balance Of Power	(0.25)
	Rate Of Daily Change	0.98
	Day Median Price	15.63
	Day Typical Price	15.69
	Price Action Indicator	(0.01)
	Period Momentum Indicator	(0.35)
	Relative Strength Index	41.3

Chemours Corporate Filings

F3	19th of February 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock	View Verify
8K	18th of February 2025 Report filed with the SEC to announce major events that shareholders should know about	View Verify
	7th of February 2025 Other Reports	View Verify
8K	2nd of December 2024 An amendment to a previously filed Form 8-K	View Verify

Chemours time-series forecasting models is one of many Chemours' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Chemours' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Chemours Stock media impact

Far too much social signal, news, headlines, and media speculation about Chemours that are available to investors today. That information is available publicly through Chemours media outlets and privately through word of mouth or via Chemours internal channels. However, regardless of the origin, that massive amount of Chemours data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Chemours news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Chemours relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Chemours' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Chemours alpha.

Chemours Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Chemours can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Chemours Historical Investor Sentiment

Investor biases related to Chemours' public news can be used to forecast risks associated with an investment in Chemours. The trend in average sentiment can be used to explain how an investor holding Chemours can time the market purely based on public headlines and social activities around Chemours Co. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Chemours' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Chemours and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Chemours news discussions. The higher the estimate score, the more favorable the investor's outlook on Chemours.

Chemours Maximum Pain Price Across April 17th 2025 Option Contracts

Chemours' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Chemours close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Chemours' options.